CLSA initiated coverage of Charles River (CRL) with an Underperform rating and $167 price target
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRL:
- FibroBiologics, Charles River establish master services agreement
- Charles River price target lowered to $205 from $210 at Barclays
- Charles River initiated with a Sell at Redburn Atlantic
- Charles River downgraded to In Line from Outperform at Evercore ISI
- Charles River, Lundbeck in deal to use Logica for neurological disease drugs